Beckett Foundation
OrganisationROR
Trials
Collaborator, Phase 2, Completed, 80 people, 8 Jan 2021
Collaborator, Phase 2/3, Completed, 72 people, 22 Jun 2009
Funded papers
23-2-10974, 27 Aug 2026
Fisetin as a senotherapeutic agent: Evidence and perspectives for age-related diseases
23-2-10655, 9 Oct 2024
Sources: api.crossref.org
Named in competing interests
Grants or research support, 28 Aug 2026
Sources: pubmed.ncbi.nlm.nih.gov